CRISPR Therapeutics AG (CRSP)

55.65 -0.76 (-1.35%) USD  |  NASDAQ  |  Apr 24, 16:00
55.93 +0.28 (+0.50%) After-Hours: 20:00
More

CRISPR Therapeutics EBITDA (Quarterly YoY Growth)

EBITDA (Quarterly YoY Growth) Chart

View EBITDA (Quarterly YoY Growth) for CRSP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EBITDA (Quarterly YoY Growth) Data

View and export this data back to 2017. Upgrade now.
Date Value
December 31, 2017 --

EBITDA Definition

EBITDA is an abbreviation for earnings before interest, taxes, depreciation, and amortization.

Read full definition.

EBITDA (Quarterly YoY Growth) Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

EBITDA (Quarterly YoY Growth) Benchmarks

Vertex Pharmaceuticals Inc Upgrade
Intellia Therapeutics Inc --
Novartis AG Upgrade
Verve Therapeutics Inc --
AC Immune SA --